Top Story

Eltrombopag provides long-term disease control in immune thrombocytopenia

April 24, 2018
In the Journals Plus

Gene therapy reduces need for transfusions in beta-thalassemia

April 18, 2018
LentiGlobin BB305 gene therapy reduced or eliminated the need for monthly transfusions among patients with transfusion-dependent beta-thalassemia, according to results…
FDA News

FDA approves Tavalisse for chronic immune thrombocytopenia

April 18, 2018
The FDA approved fostamatinib disodium hexahydrate for the treatment of adults with chronic immune thrombocytopenia who had insufficient response to a previous…
FDA News

FDA expands approval of Vonvendi for von Willebrand disease

April 17, 2018
The FDA expanded the approval of Vonvendi for the treatment of bleeding in adults with von Willebrand disease to include surgical settings, according to the…
More Headlines »

Ace the Case: 61-Year-Old Male Who Presents to the ER with Worsening Back Pain

There is no commercial support for this activity.

This “Ace the Case” activity will review the diagnosis and management of patients with high-risk multiple…
More »

VIDEO: Stem cell transplant for myeloma ‘here to stay,’ stands to improve with help of new agents

March 4, 2016
More »
Resource Centers
American Association for Cancer Research Annual Meeting

American Association for Cancer Research Annual Meeting


Virtual NSCLC: Updates in Combining Immunotherapy with Other Treatment Modalities

This activity is supported by an educational grant from Merck & Co., Inc.

Lung cancer is a leading cause of cancer death worldwide. The American Cancer Society estimates that there will be…
More »